| Terminated | DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP) NCT00302341 | Immtech Pharmaceuticals, Inc | Phase 3 |
| Completed | A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA P NCT00000784 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Pati NCT00002102 | U.S. Bioscience | N/A |
| Completed | A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia NCT00001003 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii Pneumonia NCT00000974 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis NCT00000816 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 4 |
| Completed | A Phase III Comparative Study of Dapsone / Trimethoprim and Clindamycin / Primaquine Versus Sulfamethoxazole / NCT00000640 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly NCT00000748 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) Infection NCT00005572 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected NCT00001028 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients NCT00000908 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With NCT00002292 | LyphoMed | N/A |
| Completed | A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children NCT00000811 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia NCT00001991 | Glaxo Wellcome | N/A |
| Completed | Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS NCT00002043 | Jacobus Pharmaceutical | N/A |
| Completed | A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP) NCT00002434 | U.S. Bioscience | N/A |
| Withdrawn | The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in NCT00000741 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylax NCT00002030 | Fisons | N/A |
| Completed | A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Ca NCT00001016 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Vers NCT00002120 | U.S. Bioscience | Phase 1 |
| Completed | An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Ar NCT00001990 | Glaxo Wellcome | N/A |
| Completed | A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary P NCT00000727 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patie NCT00002291 | Fisons | N/A |
| Completed | An Open, Prospective, Multicenter Study of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocy NCT00000714 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulf NCT00002056 | LyphoMed | N/A |
| Completed | A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol NCT00002053 | Fisons | N/A |
| Completed | A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who NCT00001027 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Terminated | Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients NCT00000730 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Pre NCT00000998 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia ( NCT00002283 | Jacobus Pharmaceutical | N/A |
| Completed | Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infecte NCT00000773 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for NCT00000724 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of NCT00000655 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocys NCT00001014 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected NCT00002340 | Glaxo Wellcome | Phase 3 |
| Completed | Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized NCT00000722 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii Pneumonia NCT00002317 | U.S. Bioscience | N/A |
| Completed | A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infec NCT00000802 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients NCT00000863 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis NCT00001996 | Glaxo Wellcome | Phase 2 |
| Completed | A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pent NCT00002054 | Fisons | N/A |
| Completed | A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfam NCT00002002 | Lederle Laboratories | N/A |
| Completed | A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral/Oral Sulfamethoxazole-Trim NCT00000715 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | The Safety and Efficacy of Clindamycin and Primaquine in the Treatment of Mild - Moderate Pneumocystis Carinii NCT00000717 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatmen NCT00001013 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Aerosols in the Treatment of Asymptomatic Pneumocystis Pneumonia: A Pilot Study Assessing the Effectiveness of NCT00000707 | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
| Completed | A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected Patients NCT00000991 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatr NCT00000739 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected Subjects NCT00000740 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Completed | A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protect NCT00002103 | U.S. Bioscience | N/A |
| Completed | A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Dos NCT00002055 | Fisons | N/A |